Substrate-dependent risk stratification for implantable cardioverter defibrillator therapies using cardiac magnetic resonance imaging: The importance of T1 mapping in nonischemic patients.
Simon ClaridgeSilvia MennuniThomas JacksonJonathan M BeharBradley PorterBenjamin SieniewiczJulian BostockMark O'NeillFrancis MurgatroydJaswinder GillGerald Carr-WhiteAmedeo ChiribiriReza RazaviZhong ChenChristopher Aldo RinaldiPublished in: Journal of cardiovascular electrophysiology (2017)
In the medium-long term, T1_native mapping was the only independent predictor of therapy in nonischemic patients, whereas Grayzone was a better predictor in ischemic patients. These findings suggest a potential role for T1_native mapping in the selection of patients for ICDs in a nonischemic population.
Keyphrases
- end stage renal disease
- magnetic resonance imaging
- ejection fraction
- newly diagnosed
- chronic kidney disease
- peritoneal dialysis
- prognostic factors
- mesenchymal stem cells
- oxidative stress
- atrial fibrillation
- subarachnoid hemorrhage
- cardiac resynchronization therapy
- cell therapy
- ischemia reperfusion injury
- contrast enhanced